Thalidomide for the treatment of resistant cutaneous lupus: Efficacy and safety of different therapeutic regimens

American Journal of Medicine

Volumn 118, Issue 3, 2005, Pages 246-250

  Cuadrado, Maria J ^a   Karim, Yousuf ^a   Sanna, Giovanni ^a   Smith, Elaine ^a   Khamashta, Munther A ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cutaneous lupus; Neuropathy; Remission; Therapeutic

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE; THALIDOMIDE;

ABDOMINAL PAIN; ADULT; AGED; AMENORRHEA; ARTICLE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DERMATITIS; DOSE RESPONSE; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ELECTROMYOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION; SKIN LUPUS ERYTHEMATOSUS; STATISTICAL SIGNIFICANCE; THROMBOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 14644394268     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.04.030     Document Type: Article

References (34)

1. G.W. Mellin, M. Katzenstein The saga of thalidomide neuropathy to embryopathy, with case reports and congenital abnormalities N Engl J Med 23 1962 1184 1190
2. T. Randall Thalidomide has 37 year history JAMA 263 1990 1474
3. J. Sheskin Thalidomide in the treatment of lepra reactions Clin Pharmacol Ther 6 1965 303 306
4. O. Gutiérrez-Rodriguez, P. Starusta-Bacal, O. Gutiérrez- Montes Treatment of rheumatoid arthritis the thalidomide experience J Rheumatol 16 1989 158 163
5. V. Hamuryudan, C. Mat, S. Saip Thalidomide in the treatment of the mucocutaneous lesions of Behcet's syndrome a randomised, double-blind, placebo controlled trial Ann Intern Med 128 1998 443 459
6. S. Singhal, J. Mehta, P. Eddlemon Marked anti-tumor effect from anti-angiogenesis (AA) therapy with thalidomide (T) in high risk refractory multiple myeloma Blood 92 suppl 1 1998 318 319
7. G. Reyes-Teran, J.G. Sierra-Madero, V. Martinez del Cerro Effects of thalidomide on HIV-associated wasting syndrome a randomised, double-blind, placebo-controlled clinical trial AIDS 10 1996 1501 1507
8. G.B. Vogelsang, E.R. Farmer, A.D. Hess Thalidomide for the treatment of chronic graft-versus-host disease N Engl J Med 326 1992 1055 1058
9. J. Knop, G. Bonsmann, R. Happle Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus Br J Dermatol 108 1983 461 466
10. M.Y. Karim, G. Ruiz-Irastorza, M.A. Khamashta, G.R.V. Hughes Update on therapy--thalidomide in the treatment of lupus Lupus 10 2001 188 192
11. K.F. Thomson, M.J. Goodfield Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus J Dermatol Treat 12 2001 145 147
12. D.J. Duong, G.T. Spigel, T.R. Moxley III, A.A. Gaspari American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus Arch Dermatol 135 1999 1079 1087
13. T.S. Housman, J.L. Jorizzo, M.A. McCarty, S.E. Grummer, A.B. Fleischer Jr, P.G. Sutej Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus Arch Dermatol 139 2003 50 54
14. S.J. Bowcock, S.M. Rassam, S.M. Ward, J.T. Turner, M. Laffan Thromboembolism in patients on thalidomide for myeloma Hematology 7 2002 51 53
15. E.M. Tan, A.S. Cohen, J.F. Fries The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277
16. R.J. Stevens, C. Andujar, C.J. Edwards Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus experience in sixteen consecutive patients Br J Rheumatol 36 1997 353 359
17. E.I. Sato, L.S. Assis, V.P. Lorenzi, L.E. Andrade Long-term thalidomide use in refractory cutaneous lesions of systemic lupus erythematosus Rev Assoc Med Bras 44 1998 289 293
18. M. Walchner, M. Meurer, G. Plewig, G. Messer Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus Int J Dermatol 39 2000 383 388
19. K.P. Kyriakis, G.J. Kontochristopoulos, D.N. Panteleos Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus Int J Dermatol 39 2000 218 222
20. E. Grosshans, G. Illy Thalidomide therapy for inflammatory dermatoses Int J Dermatol 23 1984 598 602
21. E. Atra, E.I. Sato Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide Clin Exp Rheumatol 11 1993 487 493
22. S. Tseng, G. Pak, K. Washenik, M.K. Pomeranz, J.L. Shupack Rediscovering thalidomide a review of its mechanism of action, side effects, and potential uses J Am Acad Dermatol 35 1996 969 979
23. S. Ochonisky, J. Verroust, S. Bastuji-Garin, R. Gherardi, J. Revuz Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients Arch Dermatol 130 1994 66 69
24. A. Rovelli, C. Arrigo, F. Nesi The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children Bone Marrow Transplant 21 1998 577 581
25. V. Chaudhry, D.R. Cornblath, A. Corse, M. Freimer, E. Simmons-O'Brien, G. Vogelsang Thalidomide-induced neuropathy Neurology 59 2002 1872 1876
26. P.M. Fullerton, D.J. O'Sullivan Thalidomide neuropathy a clinical, electrophysiological, and histological follow-up study J Neurol Neurosurg Psychol 31 1968 543 551
27. C.W. Hess, T. Hunziker, A. Kupfer, H.P. Ludin Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluation J Neurol 233 1986 83 89
28. C.C. Harland, G.B. Steventon, J.R. Marsden Thalidomide-induced neuropathy and genetic differences in drug metabolism Eur J Clin Pharmacol 49 1995 1 6
29. A. Lagueny, A. Rommel, B. Vignolly Thalidomide neuropathy an electrophysiologic study Muscle Nerve 9 1986 837 844
30. J. Ordi-Ros, F. Cortes, N. Martinez, M. Mauri, I. de Torres, M. Vilardell Thalidomide induces amenorrhea in patients with lupus disease Arthritis Rheum 41 1998 2273 2275
31. C. Frances, S. El Khoury, A. Gompler, P.A. Becherel, O. Chosidow, J.C. Piette Transient secondary amenorrhea in women treated by thalidomide Eur J Dermatol 12 2002 63 65
32. A. Gompel, C. Frances, J.C. Piette, A.S. Blanc, F. Cordoliani, A.M. Piette Ovarian failure with thalidomide treatment in complex aphtosis comment on the concise communication by Ordi et al Arthritis Rheum 42 1999 2259 2260
33. K. Osman, R. Comenzo, S.V. Rajkumar Deep vein thrombosis and thalidomide therapy for multiple myeloma N Engl J Med 344 2001 1951 1952
34. B. Flageul, D. Wallach, B. Cavalier-Balloy, H. Bachelez, F. Carsuzaa, L. Dubertret Thalidomide and thrombosis Ann Dermatol Venereol 127 2000 171 174